Prospective trial on the safety of rectal indomethacin 100mg for prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis for Japanese.
Not Applicable
Recruiting
- Conditions
- post ERCP pancreatitis
- Registration Number
- JPRN-UMIN000028900
- Lead Sponsor
- Tane General Hospital Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1 patients who are contraindicated of rectal indomethacin according to the drug information ex.) gastrointestinal ulcer, severe commorbidity(hematologic disease, liver dysfunction, renal disorder, heart failure, hypertention) history of hypersensitivity to salicylic acid-based compound procitis, rectal bleeding or hemorrhoid aspirin-induced asthma pregnancy 2 patients who don't agree to perticipate in this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of adverse event
- Secondary Outcome Measures
Name Time Method